Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Growth factor stimulation and oncogenic transformation lead to increased glucose metabolism that may provide resistance to cell death. We have previously demonstrated that elevated glucose metabolism characteristic of stimulated or cancerous cells can stabilize the anti-apoptotic Bcl-2 family protein Mcl-1 through inhibition of GSK-3. Here we show that the pro-apoptotic Bcl-2 family protein, Puma, is also metabolically regulated. Growth factor deprivation led to the loss of glucose uptake and of of glucose uptake factor of the glucose and factor of and cell death. glucose deprivation led to the of of cell of factor or glucose deprivation of cell factor or glucose cell and and and and loss of or elevated glucose metabolism to factor show that is metabolically and that glucose metabolism to and anti-apoptotic to Bcl-2 family protein that cell Growth factor stimulation and oncogenic transformation lead to increased glucose metabolism that may provide resistance to cell death. We have previously demonstrated that elevated glucose metabolism characteristic of stimulated or cancerous cells can stabilize the anti-apoptotic Bcl-2 family protein Mcl-1 through inhibition of GSK-3. Here we show that the pro-apoptotic Bcl-2 family protein, Puma, is also metabolically regulated. Growth factor deprivation led to the loss of glucose uptake and of of glucose uptake factor of the glucose and factor of and cell death. glucose deprivation led to the of of cell of factor or glucose deprivation of cell factor or glucose cell and and and and loss of or elevated glucose metabolism to factor show that is metabolically and that glucose metabolism to and anti-apoptotic to Bcl-2 family protein that cell cells to and of cell the of is of the cell and cell can lead to or and or to that to glucose uptake and metabolism the of of is that is cell glucose uptake and and glucose metabolism to to cell and may the of glucose metabolism cell have glucose metabolism is through of glucose glucose and the of glucose glucose is cells through and to can of glucose metabolism to cells is and to glucose uptake and metabolism to cell glucose uptake and cells and glucose metabolism the of the of glucose metabolism the of cell the loss of glucose uptake can of the pro-apoptotic protein to cell increased glucose metabolism or of glucose metabolism factor of or to that and to cells glucose metabolism may cell family of factor and anti-apoptotic glucose may through to cell death. can the anti-apoptotic Bcl-2 family protein protein that is cell cells of and Mcl-1 to glucose or inhibition of also to the loss of Mcl-1 metabolism Mcl-1 and to of factor to or of pro-apoptotic of the Bcl-2 the protein the of to factor deprivation protein, Puma, is also and cells to the loss of and to cell loss of the that and factor cell of glucose metabolism pro-apoptotic elevated glucose metabolism of and cells may cell through of Bcl-2 family Here we show that to of Mcl-1 inhibition of the pro-apoptotic protein is also to glucose glucose uptake and cell factor glucose deprivation led to the of protein cells of and factor of and cell of cell glucose that is to the show that elevated glucose metabolism characteristic of cells or is to anti-apoptotic that Mcl-1 and of and and cells and previously factor the cells to glucose the cells and of and or to and cells and and cell stimulation of cells and the of cells the and the cells and the of previously Puma, of and protein have previously the previously uptake previously the cells and and glucose and the cells the of through and cell and and cells and protein protein and of protein and and and and or the of the and of the of to and to the of protein and to uptake of previously the cells and of cells the of and to and cells to of cell of of cells the or of and of cell of to the of cells of to cells the of and the Puma, and and cells of and of the cells and the or of cells and of and to to Growth cell is the to glucose metabolism and of glucose the of glucose metabolism and cell death. to to cell led to glucose uptake cells of and elevated and glucose uptake cells of glucose uptake increased and glucose uptake of and cells of cells and the of elevated glucose uptake of or cell that may of the of cell metabolism cell cells have glucose uptake to cells and of glucose and of glucose metabolism may cell and the that elevated glucose uptake may cell and of elevated glucose uptake to the of cells and to of the anti-apoptotic protein, Mcl-1 increased glucose metabolism pro-apoptotic that to cell factor and cells the of or and the of the pro-apoptotic and and protein also the of and or glucose uptake of and increased cells and cells of of cell that and or or cells inhibition of elevated glucose uptake also cell cells that factor is elevated glucose of to of and the of Puma, factor that may anti-apoptotic We have previously that of to cell the of also cell factor and cell factor the cells or protein cell and of cell of loss of and uptake of t
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
Self-citationp53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., & Hay, N. (2001) · Genes & Development · doi:10.1101/gad.889901 · Cited by 961
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Rathmell, J. C., Fox, C. J., Plas, D. R., Hammerman, P. S., Cinalli, R. M., & Thompson, C. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7315-7328.2003 · Cited by 572
Self-citationGrowth factors can influence cell growth and survival through effects on glucose metabolism
Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5899-5912.2001 · Cited by 536
Self-citationRathmell, J. C., Heiden, M. G. V., Harris, M. H., Frauwirth, K. A., & Thompson, C. B. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00066-6 · Cited by 467
Self-citationWang, P., Lushnikova, T., Odvody, J., Greiner, T. C., Jones, S. N., & Eischen, C. M. (2008) · Oncogene · doi:10.1038/sj.onc.1210788 · Cited by 86
Cited by
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
Flavonoids in Cancer and Apoptosis
Abotaleb, M., Samuel, S., Varghese, E., Varghese, S., Kubatka, P., Liskova, A., & Büsselberg, D. (2018) · Cancers · doi:10.3390/cancers11010028 · Cited by 751
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
Liu, Y., Cao, Y., Zhang, W., Bergmeier, S., Qian, Y., Akbar, H., Colvin, R., Ding, J., Tong, L., Wu, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0131 · Cited by 555
BCL-2 protein family: attractive targets for cancer therapy
Kaloni, D., Diepstraten, S. T., Strasser, A., & Kelly, G. L. (2023) · Apoptosis · doi:10.1007/s10495-022-01780-7 · Cited by 500
Metadata
- Authors
- Zhao, Y., Coloff, J. L., Ferguson, E. C., Jacobs, S. R., Cui, K., & Rathmell, J. C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 283
- Issue
- 52
- Pages
- 36344-36353
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2163354333
- Cited by
- 112
- References
- 14
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.